Abeona Therapeutics Inc

詳細情報 Abeona Therapeutics Inc 企業名

Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing cell and gene therapies for life-threatening diseases. The Company’s lead clinical program is for prademagene zamikeracel (pz-cel), its investigational autologous, COL7A1 gene-corrected epidermal sheets currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company’s fully integrated cell and gene therapy Good Manufacturing Practice (cGMP) manufacturing facility served as the manufacturing site for pz-cel used in its Phase III VIITAL trial and is capable of supporting commercial production of pz-cel upon FDA approval. The Company’s development portfolio also features adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need. The Company’s novel, next-generation AAV capsids are being evaluated to improve tropism profiles for a variety of devastating diseases.

企業情報

企業コードABEO

会社名Abeona Therapeutics Inc

上場日Sep 19, 1980

最高経営責任者「CEO」Dr. Vishwas (Vish) Seshadri, Ph.D.

従業員数136

証券種類Ordinary Share

決算期末Sep 19

本社所在地6555 Carnegie Ave, 4th Floor

都市CLEVELAND

証券取引所NASDAQ Capital Market Consolidated

国United States of America

郵便番号44103

電話番号16468134701

ウェブサイトhttps://abeonatherapeutics.com/

企業コードABEO

上場日Sep 19, 1980

最高経営責任者「CEO」Dr. Vishwas (Vish) Seshadri, Ph.D.

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Dr. Vishwas (Vish) Seshadri, Ph.D.

President, Chief Executive Officer, Director

1.23M

-5.32%

Mr. Michael Amoroso

Chairman of the Board

180.47K

--

Dr. Leila Alland, M.D.

Independent Director

154.37K

--

Mr. Donald A. Wuchterl

Independent Director

145.44K

-3.44%

Ms. Christine Berni Silverstein

Independent Director

120.48K

-9.80%

Mr. Mark J. Alvino

Independent Director

77.34K

-14.48%

Dr. Bernhardt G. Zeiher, M.D.

Independent Director

47.15K

--

Dr. Eric Crombez, M.D.

Independent Director

--

Mr. Joseph Vazzano, CPA

Chief Financial Officer

--

Ms. Faith L. Charles, J.D.

Independent Director

--

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Dr. Vishwas (Vish) Seshadri, Ph.D.

President, Chief Executive Officer, Director

1.23M

-5.32%

Mr. Michael Amoroso

Chairman of the Board

180.47K

--

Dr. Leila Alland, M.D.

Independent Director

154.37K

--

Mr. Donald A. Wuchterl

Independent Director

145.44K

-3.44%

Ms. Christine Berni Silverstein

Independent Director

120.48K

-9.80%

Mr. Mark J. Alvino

Independent Director

77.34K

-14.48%

収益内訳

データなし

データなし

事業別

地域別

データなし

株主

更新時刻: Sat, Jul 12

株主統計

種類

株主統計

比率

Suvretta Capital Management, LLC

7.20%

Nantahala Capital Management, LLC

6.86%

Adage Capital Management, L.P.

5.26%

Western Standard, LLC

4.46%

The Vanguard Group, Inc.

3.95%

Other

72.27%

株主統計

比率

Suvretta Capital Management, LLC

7.20%

Nantahala Capital Management, LLC

6.86%

Adage Capital Management, L.P.

5.26%

Western Standard, LLC

4.46%

The Vanguard Group, Inc.

3.95%

Other

72.27%

種類

株主統計

比率

Hedge Fund

39.27%

Investment Advisor

9.65%

Investment Advisor/Hedge Fund

6.04%

Individual Investor

5.83%

Venture Capital

4.82%

Research Firm

3.12%

Pension Fund

0.17%

Other

31.08%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

154

35.41M

69.26%

-4.09M

2025Q1

147

35.53M

69.67%

-3.94M

2024Q4

142

35.48M

81.61%

-1.29M

2024Q3

136

33.53M

77.24%

-4.39M

2024Q2

136

35.81M

86.04%

+12.73M

2024Q1

132

18.43M

63.48%

+1.42M

2023Q4

122

17.76M

63.56%

+2.13M

2023Q3

129

13.60M

55.05%

-1.35M

2023Q2

141

10.67M

49.73%

+4.50K

2023Q1

170

7.90M

44.30%

-1.15M

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

Suvretta Capital Management, LLC

3.69M

7.2%

--

Mar 31, 2025

Nantahala Capital Management, LLC

3.51M

6.86%

-19.36K

-0.55%

Mar 31, 2025

Adage Capital Management, L.P.

2.69M

5.26%

-1.21M

-31.03%

Mar 31, 2025

Western Standard, LLC

2.28M

4.46%

+196.78K

+9.44%

Mar 31, 2025

The Vanguard Group, Inc.

2.02M

3.95%

+54.16K

+2.75%

Mar 31, 2025

Vivo Capital, LLC

1.84M

3.6%

--

Mar 31, 2025

Rosalind Advisors, Inc.

1.81M

3.53%

+427.00

+0.02%

Mar 31, 2025

Laurion Capital Management LP

1.31M

2.55%

--

Mar 31, 2025

Armistice Capital LLC

1.30M

2.54%

+1.30M

--

Dec 31, 2023

Seshadri (Vishwas)

1.30M

2.55%

-51.56K

-3.80%

Jun 06, 2025

詳細を見る

6.415USD

Abeona Therapeutics Inc

6.415

概要

企業名

金融